Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Biota Pharmaceuticals Inc    NABI   US6295191091

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
More Financials
Company
Biota Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening infectious diseases.The Company currently has two Phase 2 clinical-stage product candidates in development: laninamivir... 
More about the company
Latest news on BIOTA PHARMACEUTICALS INC
03/05 BIOTA PHARMACEUTICALS : to Present at the 27th Annual Roth Conference
03/03 Biota Pharmaceuticals to Present at the 27th Annual Roth Conference
03/03 BIOTA PHARMACEUTICALS : Commences Dosing in Vapendavir SPIRITUS Phase 2b Trial
02/26 BIOTA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Regulation F..
02/26 BIOTA PHARMACEUTICALS : to Acquire Anaconda Pharma
02/10 BIOTA PHARMACEUTICALS : Valuable Updates on Pharmaceutical Companies: New Resear..
02/06 BIOTA PHARMACEUTICALS : Reports Second Quarter Fiscal Year 2015 Financial Result..
02/06 BIOTA PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condit..
More news
Sector news : Bio Therapeutic Drugs
03/27 ISIS PHARMACEUTICALS : Earnings Coverage - Isis Pharma
03/26 Alliance invokes Elliott track record in appeal against board shake-up
03/26 ACTELION : receives marketing approval for Opsumit (macitentan) in pulmonary art..
More sector news : Bio Therapeutic Drugs
Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF